- Home
- GROW vs CRIS Comparison
GROW vs CRIS Comparison
Compare GROW & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GROW
- CRIS
- Stock Information
- Founded
- GROW 1968
- CRIS 2000
- Country
- GROW United States
- CRIS United States
- Employees
- GROW N/A
- CRIS N/A
- Industry
- GROW Investment Managers
- CRIS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- GROW Finance
- CRIS Health Care
- Exchange
- GROW Nasdaq
- CRIS Nasdaq
- Market Cap
- GROW 32.9M
- CRIS 32.8M
- IPO Year
- GROW N/A
- CRIS 2000
- Fundamental
- Price
- GROW $2.44
- CRIS $3.22
- Analyst Decision
- GROW
- CRIS Strong Buy
- Analyst Count
- GROW 0
- CRIS 3
- Target Price
- GROW N/A
- CRIS $23.00
- AVG Volume (30 Days)
- GROW 27.6K
- CRIS 33.4K
- Earning Date
- GROW 02-12-2025
- CRIS 02-25-2025
- Dividend Yield
- GROW 3.69%
- CRIS N/A
- EPS Growth
- GROW N/A
- CRIS N/A
- EPS
- GROW 0.04
- CRIS N/A
- Revenue
- GROW $9,421,000.00
- CRIS $10,259,000.00
- Revenue This Year
- GROW N/A
- CRIS N/A
- Revenue Next Year
- GROW N/A
- CRIS N/A
- P/E Ratio
- GROW $66.14
- CRIS N/A
- Revenue Growth
- GROW N/A
- CRIS 0.44
- 52 Week Low
- GROW $2.38
- CRIS $2.86
- 52 Week High
- GROW $2.95
- CRIS $17.49
- Technical
- Relative Strength Index (RSI)
- GROW 48.78
- CRIS 45.26
- Support Level
- GROW $2.43
- CRIS $3.05
- Resistance Level
- GROW $2.49
- CRIS $3.55
- Average True Range (ATR)
- GROW 0.04
- CRIS 0.19
- MACD
- GROW -0.00
- CRIS -0.01
- Stochastic Oscillator
- GROW 25.00
- CRIS 32.69
About GROW U.S. Global Investors Inc.
US Global Investors Inc is a registered investment advisory firm. The company manages the following business segments: Investment management services; through which the company offers, to U.S. Global Investors Funds (USGIF or the Funds) and exchange-traded fund (ETF) clients, a range of investment management products and services to meet the needs of individual and institutional investors; and Corporate Investments, through which the company invests for its own account in an effort to add growth and value to its cash position. It derives all its revenue from Investment management services.
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes innovative drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, advanced solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.